PEPRET-10MG

Retatrutide – 10mg

$275.00

10mg – Lyophilized *MUST BE RECONSTITUTED*

Retatrutide – a GGG tri-agonist that uniquely targets GLP-1 and GIP receptors while also activating the glucagon receptor. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists. Ideal for research applications, Retatrutide provides a promising tool for exploring advanced therapeutic strategies in metabolic health and obesity management.

Retatrutide 10mg

Retatrutide 10mg is a GGG agonist and mimic of incretin. It attaches itself to receptors for glucagon, gastric inhibitory peptide, and glucagon-like peptide-1. Clinical research has linked this triple activity to significant weight loss (24 percent of body weight at six months). Because of this result, Retatrutide is the most efficacious incretin peptide and is being thoroughly studied as a weight loss aid. There is some hope that Retatrutide may also have advantageous cardiovascular effects and could be helpful in treating heart disease overall and heart disease exacerbated by diabetes.

According to research, Retatrutide is probably the most effective incretin-based peptide for weight loss that has been created to date. For example, Retatrutide treatment for just ten days causes reductions in total body weight in rats compared to those observed with Semaglutide. When the peptides are given at identical dosages, this happens. Retatrutide has a lower risk of side effects when administered at a dose than Semaglutide, but it still results in comparable weight reduction outcomes. Therefore, for those who are relatively intolerant of the side effects of semaglutide, Retatrutide may provide an alternate course of treatment.

0